Cagrilintide Peptide| Amylin Receptor Agonist for Appetite & Metabolic Research

Cagrilintide is a long-acting synthetic peptide that targets amylin and glucagon receptors, making it a key compound in studies related to satiety signaling, energy balance, and weight regulation. It is structurally related to endogenous amylin and is often studied in combination with GLP-1 receptor agonists such as Semaglutide to enhance appetite suppression and metabolic effects.

Key Research Areas:

• Appetite regulation and satiety signaling

• Body weight control and fat metabolism

• Delayed gastric emptying and food intake reduction

• Combination studies with GLP-1 analogs (e.g. Semaglutide, Tirzepatide)

• Obesity and metabolic syndrome models

Note: For research and laboratory use only. Not intended for human or veterinary applications.